Towa Pharmaceutical Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Towa Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ¥5,250. The average 1-year stock price forecast is 42.28% higher than the current stock price, while the lowest is ¥4,400 (+19.24%) and the highest is ¥5,900 (+59.89%).

Price Target: ¥5,250 (+42.28%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	¥4,400	¥5,250	¥5,450	¥5,900
Change	+19.24%	+42.28%	+47.70%	+59.89%

* Price targets were last updated on Mar 4, 2026.

Analyst Ratings

The average analyst rating for Towa Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	3	3	3	4	4	4
Buy	0	0	0	0	0	0
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	6	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst Morgan Stanley No rating	Morgan Stanley	Hold Maintains ¥3,100 → ¥4,500	Hold	Maintains	¥3,100 → ¥4,500	+21.95%	Mar 4, 2026

Financial Forecast

Revenue This Year

303.86B

from 273.71B

11.02%

from 273.71B

Revenue Next Year

317.52B

from 303.86B

4.49%

from 303.86B

EPS This Year

n/a

from -

EPS Next Year

n/a

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	165.62B	208.86B	227.93B	259.59B	273.71B	303.86B
Revenue Growth	6.92%	26.11%	9.13%	13.89%	5.44%	11.02%
Gross Profit	70.19B	72.71B	81.38B	94.73B	99.10B	112.63B
Gross Margin	42.38%	34.81%	35.70%	36.49%	36.21%	37.07%
Operating Income	18.54B	5.52B	17.65B	23.24B	23.10B	31.92B
Net Income	15.91B	2.20B	16.17B	18.99B	5.25B	22.22B
Dividend / Share	57.00	60.00	60.00	70.00	80.00	84.67
Dividend Growth	-	5.26%	-	16.67%	14.29%	5.83%
Free Cash Flow	-1.47B	-27.06B	-32.62B	-15.70B	-2.86B	-1.80B
No. Analysts	-	-	-	-	-	6

Financial currency is JPY.

Revenue Forecast

Revenue	2027	2028	2029
High	311.6B
Avg	303.9B
Low	298.5B

Revenue Growth

Revenue Growth	2027	2028	2029
High	13.9%
Avg	11.0%
Low	9.0%

EPS Forecast

EPS	2027	2028	2029
High	-
Avg	-
Low	-

EPS Growth

EPS Growth	2028	2029
High	-
Avg	-
Low	-